ProPharma Group, LLC v. Anthony Crone

CourtDistrict Court, M.D. Florida
DecidedJune 15, 2026
Docket6:26-cv-01180
StatusUnknown

This text of ProPharma Group, LLC v. Anthony Crone (ProPharma Group, LLC v. Anthony Crone) is published on Counsel Stack Legal Research, covering District Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
ProPharma Group, LLC v. Anthony Crone, (M.D. Fla. 2026).

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA ORLANDO DIVISION

PROPHARMA GROUP, LLC,

Plaintiff,

v. Case No: 6:26-cv-1180-PGB-LHP

ANTHONY CRONE,

Defendant. / ORDER This cause comes before the Court on Plaintiff ProPharma Group, LLC’s (“Plaintiff”) Motion for Temporary Restraining Order and Preliminary Injunction (Doc. 13 (the “Motion”)), filed June 3, 2026. Upon consideration, the Court will grant Plaintiff’s Motion in part, reserve ruling in part, and deny as to the remainder. I. BACKGROUND Through this action, Plaintiff, “one of the nation’s leading pharma services companies,” brings a series of claims against its former employee, Defendant Anthony Crone (“Defendant”), after he purportedly shared sensitive client information with his new employer—Plaintiff’s direct competitor—in violation of his employment agreement with Plaintiff. (See generally Doc. 10). A. Plaintiff’s Business Operations According to the operative Verified Amended Complaint (Doc. 10 (the “Complaint”)), Plaintiff “helps pharmaceutical, biotechnology, and medical

device companies navigate regulatory, clinical, safety, compliance and medical information to bring life-changing therapies to market.” (Id. ¶ 1). Plaintiff avers that, for the past twenty-five years, it has invested substantial time and resources into developing its confidential data, business goodwill, and relationships with existing and prospective customers across the United States and abroad. (Id. ¶ 13).

Moreover, one means by which it develops these assets is through the recruitment and retention of highly skilled sales professionals who cultivate and maintain relationships with customers and prospective customers. (Id. ¶ 14). According to Plaintiff, because certain of these professionals are exposed to its confidential information and trade secrets in the course of their work, when appropriate, it requires such employees to execute restrictive covenants and confidentiality

agreements to protect this sensitive information. (Id. ¶ 18). B. Defendant’s Exposure to Plaintiff’s Sensitive Information Plaintiff avers that Defendant served as its Senior Vice President of Business Development from March 2024 to January 2026, and, through this role, was privy to Plaintiff’s “most sensitive business-development information.” (Id. ¶¶ 21, 25).

For example, Defendant was exposed to internal information regarding Plaintiff’s prospective and current customers, including their contact information; identities of their key decisionmakers; and internal notes concerning Plaintiff’s prior meetings with such customers, proposals thereto, expected account value, and the customers’ needs. (Id. ¶¶ 24–26). In addition, Defendant was also exposed to Plaintiff’s “non-public information concerning how [it] identifies, develops,

nurtures, and converts business opportunities,” and regarding its “go-to-market messaging, sales framing and methodology, competitive positioning,” and “account-prioritization strategies.” (Id. ¶ 26). C. Defendant’s Employment Agreement Plaintiff alleges that, because Defendant’s role would entail broad exposure

to its sensitive information, Plaintiff’s employment agreement with Defendant (Doc. 10-1 (the “Agreement”)) contained provisions intended to safeguard such information, including certain restrictive covenants. To begin, the Agreement contained non-solicitation provisions regarding Plaintiff’s clients and accounts (the “Non-Solicitation Provisions”), which included the following restrictions: A. The Employee agrees that any current clients with whom the Employee worked while employed by the Company or that were obtained for the Company by the Employee during the Employees employment with the Company (“Clients”) are, and shall remain the sole and exclusive property of the Company at any time during the Employee’s employment with the Company, and for a period of one (1) year thereafter . . . , Employee agrees that Employee will not, directly or indirectly induce, attempt to induce, or act in a manner that is reasonably likely to cause any Clients to cease doing business with or decrease the volume or amount of business done with the Company or to transfer their business, to any competitor of the Company. . . .

C. The Employee agrees not to perform similar work or services that Employee provided to the Company on behalf of (1) any validation or related industry contractors which provide services to clients or other contractors for whom the Employee has provided services under this Agreement, or (2) clients to which Company has marketed the services of the Employee within the last twelve (12) months of Employee’s employment. This restriction is limited to a period of twelve (12) months following the last day of work on any project or twelve (12) months from the date of resume submission, whichever is later.

(Id. at pp. 5–6). The Non-Solicitation Provisions applied only to the geographical areas in which Defendant “provided services or had a material presence or influence within the last two (2) years” of his employment by Plaintiff. (Id. at p. 6). Moreover, the terms “client” and “other contractor” were defined as “any person or entity who or which used Company’s services at any time during the two (2)- year period preceding termination of [the] Agreement.” (Id.). Finally, through the Non-Solicitation Provisions, Defendant agreed that: E. The Company has a legitimate business interest in enforcement of the restrictions contained in this Agreement, including without limitation, the Company’s need to protect the goodwill of the Company, its investment in training of the Employee, the client and vendor relationships of the Company, the stability of the Company’s workforce, and the confidentiality of the Company’s business information and other legitimate interests.

(Id.). The Agreement also contains provisions regarding the non-disclosure of Plaintiff’s trade secrets and its confidential information (the “Non-Disclosure Provisions”). (Id. at pp. 6–10). In relevant part, through the Non-Disclosure Provisions, Defendant acknowledged that his employment with Defendant would cause him to be exposed to Plaintiffs’ trade secrets and other confidential information. (Id. at pp. 6–7). The Non-Disclosure Provisions expressly defined “[t]rade [s]ecrets,” to include Plaintiff’s “files and records regarding customers [and] prospective customers . . . such as contact information; customer lists;

prospective customer lists; [and] customer profiles . . . .” (Id. at p. 6). Moreover, it defined “confidential information” to include “lists and information about clients [and] customers.” (Id. at p. 7). By signing the Agreement, Defendant agreed that all of Plaintiff’s trade secrets and confidential information would “forever be maintained in confidence”

by Defendant and that such information would be used by Defendant “only to such extent as may be necessary in the ordinary course of performing services for [Plaintiff] under [the] Agreement.” (Id.). Finally, Defendant agreed that, upon the termination of his employment with Plaintiff, or “at the request of [Plaintiff] at any time,” Defendant would “immediately deliver” to Plaintiff its trade secrets and confidential information. (Id. at pp. 9–10). The Non-Disclosure Provisions further

noted that Defendant “may be required to certify in writing that [he] has complied with these requirements.” (Id. at p. 10). Finally, the Agreement contains a section that predetermines remedies in the event of a breach of its terms (the “Remedies Provision”). (Id. at pp. 11–12). Through the Remedies Provision, Defendant “agree[d] that the harm that might

result to [Plaintiff] of [Defendant’s] non-compliance with this Agreement that endangers [Plaintiff]’s business relationships or prospects would be irreparable.” (Id. at p. 11).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Theresa Marie Schindler Schiavo v. Michael Schiavo
403 F.3d 1223 (Eleventh Circuit, 2005)
4uortho, LLC v. Practice Partners, Inc.
18 So. 3d 41 (District Court of Appeal of Florida, 2009)
ENVIRONMENTAL SERVICES, INC. v. Carter
9 So. 3d 1258 (District Court of Appeal of Florida, 2009)
Autonation, Inc. v. O'BRIEN
347 F. Supp. 2d 1299 (S.D. Florida, 2004)
Miccosukee Tribe of Indians of Florida v. United States
571 F. Supp. 2d 1280 (S.D. Florida, 2008)
North American Products Corp. v. Moore
196 F. Supp. 2d 1217 (M.D. Florida, 2002)
Deauville Hotel Management, LLC, Etc. v. Ward
219 So. 3d 949 (District Court of Appeal of Florida, 2017)
Vital Pharmaceuticals, Inc. v. Christopher Alfieri
23 F.4th 1282 (Eleventh Circuit, 2022)
Vas Aero Services, LLC v. Arroyo
860 F. Supp. 2d 1349 (S.D. Florida, 2012)
7-Eleven, Inc. v. Kapoor Bros.
977 F. Supp. 2d 1211 (M.D. Florida, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
ProPharma Group, LLC v. Anthony Crone, Counsel Stack Legal Research, https://law.counselstack.com/opinion/propharma-group-llc-v-anthony-crone-flmd-2026.